Skip to main content
. 2017 May 11;18(5):1035. doi: 10.3390/ijms18051035
ALK Anaplastic lymphoma kinase
BOR Best Overall Response
cfDNA cell-free tumor DNA
CL Confidence Limits
CT Cycle Threshold
CTCs Circulating Tumor Cells
CT-scan Computed Tomography
ECOG PS Eastern Cooperative Oncology Group Performance Status
EDTA Ethylenediamine tetraacetic acid
EGFR Epidermal growth factor receptor
EpCAM Epithelial Cell Adhesion Molecule
GM Geometrical Mean
H&E Haematoxylin-Eosin
HR Hazard Ratio
hTERT human Telomerase Reverse Transcriptase
NSCLC Non-small cell lung cancer
OS Overall Survival
PD Progressive Disease
PFS Progression-Free Survival
PR Partial Response
qPCR quantitative PCR
RECIST Response Evaluation Criteria in Solid Tumors
SD Stable Disease